Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93

1.

Ultrasound-sensitizing nanoparticle complex for overcoming the blood-brain barrier: an effective drug delivery system.

Ha SW, Hwang K, Jin J, Cho AS, Kim TY, Hwang SI, Lee HJ, Kim CY.

Int J Nanomedicine. 2019 May 24;14:3743-3752. doi: 10.2147/IJN.S193258. eCollection 2019.

2.

The Classification of Renal Cancer in 3-Phase CT Images Using a Deep Learning Method.

Han S, Hwang SI, Lee HJ.

J Digit Imaging. 2019 May 16. doi: 10.1007/s10278-019-00230-2. [Epub ahead of print]

PMID:
31098732
3.

Antitumor Effects of Intra-Arterial Delivery of Albumin-Doxorubicin Nanoparticle Conjugated Microbubbles Combined with Ultrasound-Targeted Microbubble Activation on VX2 Rabbit Liver Tumors.

Lee JH, Moon H, Han H, Lee IJ, Kim D, Lee HJ, Ha SW, Kim H, Chung JW.

Cancers (Basel). 2019 Apr 24;11(4). pii: E581. doi: 10.3390/cancers11040581.

4.

An ultrasound-responsive dual-modal US/T1 -MRI contrast agent for potential diagnosis of prostate cancer.

Yoon YI, Ha SW, Lee HJ.

J Magn Reson Imaging. 2018 Dec;48(6):1610-1616. doi: 10.1002/jmri.26217.

PMID:
30475452
5.

Outcomes of magnetic resonance imaging fusion-targeted biopsy of prostate imaging reporting and data system 3 lesions.

Kim TJ, Lee MS, Hwang SI, Lee HJ, Hong SK.

World J Urol. 2018 Nov 20. doi: 10.1007/s00345-018-2565-3. [Epub ahead of print]

PMID:
30460594
6.

Value of MR-US fusion in guidance of repeated prostate biopsy in men with PSA < 10 ng/mL.

Hwang SI, Lee HJ, Lee SE, Hong SK, Byun SS, Lee SC, Choe G.

Clin Imaging. 2019 Jan - Feb;53:1-5. doi: 10.1016/j.clinimag.2018.09.012. Epub 2018 Sep 22.

PMID:
30265884
7.

A negative multiparametric magnetic resonance imaging finding does not guarantee the absence of significant cancer among biopsy-proven prostate cancer patients: a real-life clinical experience.

Kim JJ, Byun SS, Lee SE, Lee HJ, Choe G, Hong SK.

Int Urol Nephrol. 2018 Nov;50(11):1989-1997. doi: 10.1007/s11255-018-1986-7. Epub 2018 Sep 18.

PMID:
30229465
8.

The Effect of Gamification through a Virtual Reality on Preoperative Anxiety in Pediatric Patients Undergoing General Anesthesia: A Prospective, Randomized, and Controlled Trial.

Ryu JH, Park JW, Nahm FS, Jeon YT, Oh AY, Lee HJ, Kim JH, Han SH.

J Clin Med. 2018 Sep 17;7(9). pii: E284. doi: 10.3390/jcm7090284.

9.

Clinical Importance of Antibiotic Regimen in Transrectal Ultrasound-Guided Prostate Biopsy: A Single Center Analysis of Nine Thousand Four Hundred Eighty-Seven Cases.

Seo YE, Ryu H, Oh JJ, Jeong SJ, Hwang SI, Lee HJ, Hong SK, Byun SS, Lee SE, Lee S.

Surg Infect (Larchmt). 2018 Oct;19(7):704-710. doi: 10.1089/sur.2018.094. Epub 2018 Sep 18.

PMID:
30227106
10.

Personalized 3D kidney model produced by rapid prototyping method and its usefulness in clinical applications.

Lee H, Nguyen NH, Hwang SI, Lee HJ, Hong SK, Byun SS.

Int Braz J Urol. 2018 Sep-Oct;44(5):952-957. doi: 10.1590/S1677-5538.IBJU.2018.0162.

11.

Diagnostic performance of diffusion-weighted imaging for prostate cancer: Peripheral zone versus transition zone.

Lee H, Hwang SI, Lee HJ, Byun SS, Lee SE, Hong SK.

PLoS One. 2018 Jun 22;13(6):e0199636. doi: 10.1371/journal.pone.0199636. eCollection 2018.

12.
13.

Multimodality Imaging in Patients with Secondary Hypertension: With a Focus on Appropriate Imaging Approaches Depending on the Etiologies.

Ahn H, Chun EJ, Lee HJ, Hwang SI, Choi DJ, Chae IH, Lee KW.

Korean J Radiol. 2018 Mar-Apr;19(2):272-283. doi: 10.3348/kjr.2018.19.2.272. Epub 2018 Feb 22.

14.

Relationship of renal morphology on 3-dimensional ultrasonography with renal pathologic findings and outcome in biopsy-proven nephropathy.

Xu J, Hwang SI, Lee HJ, Chin HJ.

Exp Ther Med. 2018 Feb;15(2):2088-2096. doi: 10.3892/etm.2017.5626. Epub 2017 Dec 13.

15.

Efficacy of the multidisciplinary tumor board conference in gynecologic oncology: A prospective study.

Lee B, Kim K, Choi JY, Suh DH, No JH, Lee HY, Eom KY, Kim H, Hwang SI, Lee HJ, Kim YB.

Medicine (Baltimore). 2017 Dec;96(48):e8089. doi: 10.1097/MD.0000000000008089.

16.
17.

Ultrasound contrast-enhanced study as an imaging biomarker for anti-cancer drug treatment: preliminary study with paclitaxel in a xenograft mouse tumor model (secondary publication).

Lee HJ, Hwang SI, Byun J, Kong HY, Jung HS, Kang M.

Ultrasonography. 2017 Oct;36(4):370-377. doi: 10.14366/usg.17015. Epub 2017 Feb 14.

18.

Synthesis of ultrasound contrast agents: characteristics and size distribution analysis (secondary publication).

Lee HJ, Yoon TJ, Yoon YI.

Ultrasonography. 2017 Oct;36(4):378-384. doi: 10.14366/usg.17014. Epub 2017 Feb 14.

19.

Magnetic Resonance Imaging as a Valuable Tool for Predicting Parametrial Invasion in Stage IB1 to IIA2 Cervical Cancer.

Kim M, Suh DH, Kim K, Lee HJ, Kim YB, No JH.

Int J Gynecol Cancer. 2017 Feb;27(2):332-338. doi: 10.1097/IGC.0000000000000878.

PMID:
30814230
20.

Magnetic Resonance Imaging as a Valuable Tool for Predicting Parametrial Invasion in Stage IB1 to IIA2 Cervical Cancer.

Kim M, Suh DH, Kim K, Lee HJ, Kim YB, No JH.

Int J Gynecol Cancer. 2017 Feb;27(2):332-338. doi: 10.1097/IGC.0000000000000878.

PMID:
28114236

Supplemental Content

Loading ...
Support Center